Entresto puts Novartis at top of docs' ranking of heart disease drug makers, with Pfizer close behind
In an ongoing battle for dominance in the eyes of healthcare professionals for their work developing heart-disease-focused drugs, Novartis has now snatched the top spot from Pfizer, according to a recent report from ZoomRx. For the latest iteration of its …